Company profile

Synapse Medicine

Pharmacy & Medication Management

Company profile

About Synapse Medicine

Synapse Medicine is a healthcare technology company specializing in medication intelligence and clinical decision support systems. The company develops React Native components that seamlessly integrate into electronic health records (EHRs), e-prescribing software, and other clinical workflows to provide real-time medication guidance. Their platform aggregates official drug databases and employs artificial intelligence algorithms to deliver personalized clinical decision support, helping healthcare providers make safer and more efficient prescribing decisions. The company's flagship product, Synapse Prescribe, is ONC-certified and designed to reduce medication-related risks, prevent adverse drug reactions, and combat alert fatigue through intelligent, context-aware notifications. Synapse Medicine serves healthcare systems, telemedicine platforms, and software providers across multiple markets including the United States, France, and Japan. The company has established partnerships with major healthcare technology providers including CompuGroup Medical, Hellocare, and Lifen, and their technology is used by thousands of healthcare professionals daily. With a strong focus on research and development, Synapse Medicine continues to innovate in areas such as pharmacovigilance automation, herb-drug interaction databases, and precision medicine applications of AI.

Company description Synapse Medicine official website

Primary marketPharmacy & Medication Management
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Synapse Medicine?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cancer
  • COVID-19
  • General medication management
  • Infectious diseases
  • Tropical diseases

Who it serves

  • Cancer Centers
  • E-prescribing Software Providers
  • EHR Vendors
  • Health Systems
  • Telemedicine Platforms
  • University Hospitals

Deployment & integration

Api Only · Cloud Saas deployment with recorded integration context.

Recorded integration context: Cerner, CompuGroup Medical, Epic, Hellocare, Lifen Platform, Surescripts.

Geographic context

MarketsEurope · France · Japan · United States
Company sourceOfficial website

Company milestones

Platform expansion

Partnership with CompuGroup Medical announced May 2023. Gustave Roussy Institute integration February 2023. ONC certification achieved May 2025. COVID-19 platform helped 700,000+ people.

Partnerships

Recorded partners

  • Bordeaux University Hospitals
  • CompuGroup Medical (CGM)
  • Gustave Roussy Institute
  • Hellocare
  • Lifen
  • MesDocteurs
  • Surescripts

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Drug Data Import Component

Component that optimizes patient treatment transcription, saving time and reducing errors

Software · Api OnlyCompany source

Medication Shield

AI-powered pharmacovigilance technology for analyzing adverse drug reaction reports

Software · Cloud SaaSCompany source

PHYDGI Database

Phytotherapy drug-interaction database for consistent herb-drug interaction risk assessment

Software · Cloud SaaSCompany source

Synapse Prescribe

Clinical decision support components for medication management integrated into EHRs and e-prescribing software

Platform · Api OnlyCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Medication safety improvement

Reducing medication-related risks and adverse drug reactions

Alert fatigue reduction

Context-aware, personalized clinical notifications

Time savings

Streamlined prescription workflows and automated data transcription

700,000+ people helped

COVID-19 platform usage

CompuGroup Medical (CGM)

Partnership to revolutionize prescribing and clinical decision support for physicians

Brings users and patients innovation in clinical decision support, fits into roadmap for safer and more efficient healthcare system

Gustave Roussy Institute

Integration of Synapse Platform for clinical pharmacy and medication reconciliation at Europe's leading cancer center

Europe's leading cancer center and third-ranked globally chose Synapse Medicine for medication management

Bordeaux University Hospitals - COVERAGE Clinical Trial

Clinical trial support for infectious disease research led by Professor Denis Malvy

Supported clinical trial promoted by Bordeaux University Hospitals for infectious disease research

MesDocteurs

Telemedicine platform using Synapse Medicine to ensure prescription safety during telehealth consultations

Simplified and smoothed healthcare pathways through secure telemedicine prescribing

COVID-19 Platform Users

Built COVID-19 platform in 72 hours to help healthcare professionals and general public during pandemic

Helped 700,000+ people with COVID-19 medication guidance and information

Hellocare

Integration of Synapse Medicine's API and components into Hellocare platform for safer prescribing in telehealth consultations

Makes it easier to prescribe safely, ensures safety of telehealth consultations while facilitating real-time decision-making

Lifen

Partnership to extend interoperability to medication reconciliation and medication management of patients

Continues desire to improve patient care through enhanced medication management capabilities

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Dr. Clément Goehrs

Co-Founder & CEO

LinkedIn

Franck Frayer

SVP Europe

Morgan Angelini

CTO

Franck le Ouay

CEO

Marie-Laure Saillard

CEO

06 · Company updates

Updates from Synapse Medicine

Recent articles published on Synapse Medicine's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Pharmacy & Medication Management

Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon